Dna X (SONM) Total Non-Current Liabilities (2018 - 2025)
Dna X filings provide 8 years of Total Non-Current Liabilities readings, the most recent being $50.5 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 15.35% to $50.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.5 million, a 15.35% increase, with the full-year FY2025 number at $50.5 million, up 15.35% from a year prior.
- Total Non-Current Liabilities hit $50.5 million in Q4 2025 for Dna X, up from $39.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $50.5 million in Q4 2025 to a low of $20.1 million in Q1 2021.
- Median Total Non-Current Liabilities over the past 5 years was $30.2 million (2023), compared with a mean of $30.7 million.
- Biggest five-year swings in Total Non-Current Liabilities: dropped 29.33% in 2024 and later skyrocketed 68.02% in 2025.
- Dna X's Total Non-Current Liabilities stood at $21.1 million in 2021, then skyrocketed by 53.02% to $32.2 million in 2022, then fell by 0.2% to $32.1 million in 2023, then soared by 36.06% to $43.7 million in 2024, then grew by 15.35% to $50.5 million in 2025.
- The last three reported values for Total Non-Current Liabilities were $50.5 million (Q4 2025), $39.1 million (Q3 2025), and $35.7 million (Q2 2025) per Business Quant data.